Canine Atopic Dermatitis Market 2022-2026 | Increased Humanization of Pets to Drive Market | Growth, trends and forecasts (2022

Strict global regulatory requirements to hamper market growth

NEW YORK, February 10, 2022 /PRNewswire/ — The Canine Atopic Dermatitis Market the value is expected to grow by $319.37 milliongrowing at a CAGR of 7.75% from 2021 to 2026, according to Technavio’s latest report

Technavio has announced its latest market research report titled Canine Atopic Dermatitis Market by Product and Geography – Forecast and Analysis 2022-2026

Know the exact growth variance and annual growth rate Request a free sample report

Rising Humanization of Pets to Support Market Growth:

Pet owners are looking for good health products and veterinary services to improve the health and lifespan of their pets. This is evident in both emerging and developed markets. Globally, pet owners ensure that the quality of ingredients and manufacturing standards of all pet care products are as good as those intended and used by humans. Younger generation pet owners are making efforts to pamper their pets. Expectations and demands for pet wellness products are constantly increasing, which is driving the demand for canine atopic dermatitis treatment drugs over the forecast period.

Strict global regulatory requirements are hampering market growth:

Manufacturers are required to adhere to the strict regulatory requirements implemented to avoid the consequences. In addition, new veterinary drugs include an approved application before being imported from one country to another. Drug applications include an Approved New Animal Drug Application (NADA), abbreviated NADA (ANADA), Investigational New Animal Drug Application (INAD), Generic Experimental New Animal Drug Application (JINDA), Conditional Approval (CNADA) or Index List. Therefore, the presence of such stringent regulations may hamper the demand for drugs to treat canine atopic dermatitis during the forecast period.

Download a free sample report for insights on drivers and challenges that will help companies assess and develop growth strategies for 2022-2026.

Canine Atopic Dermatitis Market 2022-2026: Segmentation

For more information on the market share and contribution of different regions and segments Request a FREE sample now!

Canine Atopic Dermatitis Market 2022-2026: Scope

Our Canine Atopic Dermatitis Market report covers the following areas:

Canine Atopic Dermatitis Market 2022-2026: Vendor Analysis

The Canine Atopic Dermatitis market is fragmented and the vendors are deploying growth strategies such as low pricing strategies and building their customer base in local or regional markets to compete in the market. Bioceltix Spolka Akcyjna, Ceva Sante Animale, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Novartis AG, Toray Industries Inc., Vetoquinol UK Ltd., Vimian Group AB, Virbac and Zoetis Inc. are some of the major market players. .

Subscribe to our “Lite Plan” billed annually to $3000 which allows you to download 3 reports/year and view 3 reports/month.

Canine Atopic Dermatitis Market 2022-2026: Key Highlights

  • Market CAGR over the forecast period 2022-2026

  • In-depth information on factors that will contribute to the growth of the Canine Atopic Dermatitis market over the next five years

  • Estimation of the Canine Atopic Dermatitis market size and its contribution to the parent market

  • Predictions on upcoming trends and changes in consumer behavior

  • The growth of the canine atopic dermatitis market

  • Market Competitive Landscape Analysis and Detailed Vendor Information

  • Comprehensive details of the factors that will challenge the growth of the Canine Atopic Dermatitis Market vendors

Related reports:

Companion Animal Specialty Drugs Market by Product and Geography – Forecast and Analysis 2021-2025: The pet specialty medicines market value is expected to increase by USD 2.80 billion at a CAGR of 5.20% during the period 2021-2025. For more information on research: Download our FREE sample report

Animal Growth Stimulators Market by Product and Geography – Forecast and Analysis 2021-2025: The animal growth enhancers market has the potential to grow USD 4.63 billion during the period 2021-2025, and the growth momentum of the market will accelerate at a CAGR of 6.81%. For more information on research: Download our latest FREE sample report

Scope of the Canine Atopic Dermatitis Market

Report cover

Details

Page number

120

base year

2021

Forecast period

2022-2026

Growth momentum and CAGR

Accelerate at a CAGR of 7.75%

Market Growth 2022-2026

$319.37 million

Market structure

Fragmented

Annual growth (%)

4.03

Regional analysis

North America, Europe, Asia and ROW

Successful market contribution

North America at 37%

Main consumer countries

United States, Canada, United Kingdom, Brazil, Germany and China

Competitive landscape

Leading companies, competitive strategies, scope of consumer engagement

Profiled companies

Bioceltix Spolka Akcyjna, Ceva Santé Animale, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Novartis AG, Toray Industries Inc., Vetoquinol UK Ltd., Vimian Group AB, Virbac and Zoetis Inc.

Market dynamics

Parent Market Analysis, Market Growth Drivers and Barriers, Fast and Slow Growing Segment Analysis, Impact of COVID-19 and Future Consumer Dynamics, Market Condition Analysis for the Forecast Period,

Customization overview

If our report does not include the data you are looking for, you can contact our analysts and customize the segments.

Contents:

Summary

Market landscape

  • Market ecosystem

  • Value chain analysis

Market sizing

Five forces analysis

Market segmentation by product

  • Market segments

  • Comparison by product

  • Antihistamines – Market size and forecast 2021-2026

  • Glucocorticoids – Market size and forecast 2021-2026

  • Progestogen compounds – Market size and forecast 2021-2026

  • Others – Market size and forecast 2021-2026

  • Market opportunity by product

Customer landscape

Geographic landscape

  • Geographic segmentation

  • Geographic comparison

  • North America – Market size and forecast 2021-2026

  • Europe – Market size and forecast 2021-2026

  • Asia – Market size and forecast 2021-2026

  • ROW – Market size and forecast 2021-2026

  • Main leading countries

  • Market Opportunity by Geography

  • Market factors

  • Market challenges

  • Market trends

Supplier Landscape

  • Overview

  • Landscape disturbance

Vendor analysis

  • Suppliers Covered

  • Positioning on the supplier market

  • Bioceltix Spolka Akcyjna

  • Ceva Animal Health

  • Dechra Pharmaceuticals Plc

  • Elanco Animal Health Inc.

  • Novartis AG

  • Toray Industries Inc.

  • Vetoquinol UK Ltd.

  • Vimian Group AB

  • Virbac

  • Zoetis Inc.

appendix

About Us

Technavio is a global leader in technology research and consulting. Their research and analysis focuses on emerging market trends and provides actionable insights to help companies identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialist analysts, Technavio’s reporting library consists of over 17,000 reports and counts, spanning 800 technologies, spanning 50 countries. Their customer base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing customer base relies on Technavio’s comprehensive coverage, in-depth research, and actionable market intelligence to identify opportunities in existing markets and potentials and assess their competitive positions in changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Manager
USA: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Technavio (PRNewsfoto/Technavio)

Technavio (PRNewsfoto/Technavio)

Quote

Quote

View original content to download multimedia: https://www.prnewswire.com/news-releases/canine-atopic-dermatitis-market-2022-2026–increase-in-pet-humanization-to-drive-market- -growth-trends-and-forecast-2022—2026-301478667.html

SOURCETechnavio


Source link

Comments are closed.